Can I Get a Michigan Medical Marijuana Card for Parkinson's Disease?
Progressive neurodegenerative disorder affecting movement, sleep, and autonomic function.
Yes — parkinson's disease qualifies under the Michigan Medical Marihuana Program
Parkinson's disease is a Category C qualifying condition on the Michigan MMMP Physician Certification Form, added during the 2018 expansion. PD is a progressive neurodegenerative disorder with a complex symptom burden — motor symptoms (tremor, rigidity, bradykinesia) plus non-motor symptoms (sleep disruption, mood changes, pain, autonomic dysfunction) that are often inadequately controlled by levodopa alone. Medical cannabis is one of several adjunctive options PD patients use for symptom management, particularly for sleep, pain, and in some patients, motor symptoms.
Common symptoms
- Resting tremor
- Bradykinesia (slowness of movement)
- Muscle rigidity
- Postural instability
- Sleep disturbance and REM sleep behavior disorder
- Levodopa-induced dyskinesias
- Anxiety and depression
- Pain (musculoskeletal and dystonic)
How medical cannabis may help
Cannabinoids interact with the endocannabinoid system, which is widely distributed in the basal ganglia — the brain region most affected by PD. THC and CBD have been studied for several PD-related symptoms: tremor, levodopa-induced dyskinesia, REM sleep behavior disorder, anxiety, and pain. CBD specifically has been studied for PD-related psychosis and sleep disturbance. Many PD patients find cannabis useful as a multi-symptom tool — addressing sleep, pain, and anxiety simultaneously rather than stacking sedatives, analgesics, and anxiolytics.
Evidence base
Several small clinical trials and observational studies have examined cannabis in PD. Chagas et al. (2014, Journal of Psychopharmacology) found CBD improved quality of life in PD patients. Lotan et al. (2014) reported reductions in tremor, rigidity, bradykinesia, sleep, and pain after smoked cannabis in 22 PD patients. A 2020 patient survey published in Movement Disorders reported that approximately 85% of PD patients using cannabis perceived benefit, though controlled-trial evidence remains limited.
Michigan certification requirements
Documentation of your Parkinson's diagnosis from a neurologist or movement-disorder specialist is helpful — recent neurology notes, current medication list (carbidopa-levodopa, dopamine agonists, MAO-B inhibitors), and any record of dyskinesia or motor fluctuations. Coordination with your neurologist about adding cannabis is strongly recommended given the complexity of PD pharmacotherapy.
Frequently Asked Questions
- Will cannabis interact with my levodopa or other Parkinson's medications?
- Cannabinoids do not have major pharmacokinetic interactions with carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, or COMT inhibitors. However, cannabis can have additive sedative effects with anticholinergics and dopamine agonists. Dr. Vance will review your specific regimen during the consultation.
- Can cannabis slow Parkinson's progression?
- No. Medical cannabis is used for symptom management — particularly sleep, pain, anxiety, and in some patients tremor or dyskinesia. It is not a disease-modifying therapy. Continue your prescribed PD medications under the care of your neurologist.